Psychiatry

Latest News


CME Content


The FDA has sent a letter to 30 companies warning that it hasn’t approved beverages containing both caffeine and alcohol, and that it intends to begin removing such products from store shelves in 30 days if the companies can’t explain why such products are safe and legal.

Alzheimer's Disease

By

Dr. Nina Silverberg of the National Institute on Aging, discusses Alzheimer's Disease.

With the help of functional MRI (fMRI), Italian researchers at the University of Udine have found that in patients who suffer from stress-related psychiatric disorders, the neural circuitry that links the prefrontal cortex to the hippocampus is dysfunctional, hampering memory suppression.

Andy Josephson, MD, is an assistant professor of neurology at the University of California, San Francisco, where he directs the Neurohospitalist Program.

Although deep brain stimulation (DBS) is typically used as a last resort treatment for people with Parkinson’s disease (and other neurological and psychiatric disorders), it is important that technology and research companies remain up to date on recent developments to make it easier to treat patients with these diseases.